Patient Stories How DCVax Works FAQs Clinical Trials Available Company Management Contact Us Related Links Scientific Publications Dr. John Trusheim, Director of Neuro-Oncology at the Virginia Piper Cancer Institute, explains the importance of immunotherapies and the apparent effectiveness of DC-Vax. Dr. Andrew Sloan, Peter D. Cristal Chair of Neurosurgical Oncology at Case Western Reserve School of Medicine, discusses the DC-Vax technology and the promising clinical data seen to-date.

Contact Us Northwest Biotherapeutics Headquarters 4800 Montgomery Lane, Suite 800 Bethesda, MD 20814 Phone: 240-497-9024 For patient related inquiries, please CLICK HERE For physician related inquiries: physicians@nwbio.com For investor related inquiries: investors@nwbio.com For media related inquiries: media@nwbio.com For job related inquiries: jobs@nwbio.com To subscribe to our mailing list, please CLICK HERE

Copyright © 2011 Northwest Biotherapeutics, Inc. | Forward-Looking Statements | Legal Disclaimer | Privacy Policy